Punjab Reports Rising Buprenorphine Procurement and Patient Registrations for Addiction Treatment
Punjab procured 43.44 crore Buprenorphine tablets over 4.5 years to support opioid substitution therapy, with annual procurement rising from 7 crore in 2022 to 11 crore in 2025. The number of patients registered at Outpatient Opioid Assisted Treatment clinics increased from about 2 lakh in 2022 to over 3.17 lakh in 2026. A significant rise in tablet supply to Punjab jails, reaching 8.87 crore in 2026, reflects growing addiction among inmates. Officials note that patients on supervised Buprenorphine are considered de-addicted, though the government has not specified full recovery rates.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is neutral (48/100). Lens Score 60/100.
Outlets measured: indianexpress, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 2 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (42–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 6 Aug, 08:05 am. Other outlets followed.